BARINTHUS BIOTHERAPEUTICS PLC Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
BARINTHUS BIOTHERAPEUTICS PLC (BRNS) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 8.78 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-06
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 8.78K shares, a 99.35% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 1.47M shares, a 32.23% decline from fiscal 2024.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 2.17M shares, a 5.15% decline from fiscal 2023.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 2.29M shares, a 0.35% decline from fiscal 2022.
- BARINTHUS BIOTHERAPEUTICS PLC share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 2.30M shares, a 17.92% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 8.78K shares 10-Q · filed 2026-08-06 | 8.78K shares derived: sum of 3 quarters · filed 2026-08-06 | 8.78K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 8.78K shares 10-Q · filed 2026-04-30 | 8.78K shares derived: sum of 2 quarters · filed 2026-04-30 | 8.78K shares derived: sum of 3 quarters · filed 2026-04-30 | 129.82K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 0.00 shares derived: sum of 2 quarters · filed 2026-03-13 | 121.04K shares derived: sum of 3 quarters · filed 2026-08-06 | 1.47M shares 10-K · filed 2026-03-13 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 121.04K shares derived: sum of 2 quarters · filed 2026-08-06 | 1.47M shares 10-Q · filed 2025-11-07 | 1.69M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | 121.04K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 1.47M shares 10-Q · filed 2026-08-06 | 1.69M shares derived: sum of 3 quarters · filed 2026-08-06 | 1.69M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | 1.35M shares 10-Q · filed 2026-04-30 | 1.57M shares derived: sum of 2 quarters · filed 2026-04-30 | 1.57M shares derived: sum of 3 quarters · filed 2026-04-30 | 1.89M shares derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | 216.93K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | 218.97K shares derived: sum of 2 quarters · filed 2025-11-07 | 542.39K shares derived: sum of 3 quarters · filed 2025-11-07 | 2.17M shares 10-K · filed 2025-03-20 |
| 2024-09-30 | 2.04K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | 325.46K shares derived: sum of 2 quarters · filed 2025-11-07 | 1.95M shares 10-Q · filed 2025-11-07 | 2.02M shares derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | 323.42K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.95M shares 10-Q · filed 2025-08-07 | 2.02M shares derived: sum of 3 quarters · filed 2025-08-07 | 2.10M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | 1.63M shares 10-Q · filed 2025-05-07 | 1.69M shares derived: sum of 2 quarters · filed 2025-05-07 | 1.77M shares derived: sum of 3 quarters · filed 2025-05-07 | 1.93M shares derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | 66.53K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | 145.33K shares derived: sum of 2 quarters · filed 2024-11-06 | 300.95K shares derived: sum of 3 quarters · filed 2024-11-06 | 2.29M shares 10-K · filed 2024-03-20 |
| 2023-09-30 | 78.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 234.42K shares derived: sum of 2 quarters · filed 2024-11-06 | 2.22M shares 10-Q · filed 2024-11-06 | |
| 2023-06-30 | 155.62K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 2.14M shares 10-Q · filed 2024-08-08 | ||
| 2023-03-31 | 1.99M shares 10-Q · filed 2024-05-13 | |||
| 2022-12-31 | 2.30M shares 10-K · filed 2023-03-24 | |||
| 2021-12-31 | 1.95M shares 10-K · filed 2022-03-25 |